Shares of Danaher Co. (NYSE:DHR – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty ratings firms that are covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $287.05.
DHR has been the subject of a number of research reports. Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target for the company in a research report on Friday, December 13th. KeyCorp upped their target price on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Robert W. Baird cut their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Stifel Nicolaus increased their price objective on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Finally, Barclays lowered their target price on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 23rd.
Get Our Latest Stock Analysis on Danaher
Hedge Funds Weigh In On Danaher
Danaher Stock Performance
Shares of DHR stock opened at $234.84 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher has a 12-month low of $222.53 and a 12-month high of $281.70. The company has a market cap of $169.62 billion, a price-to-earnings ratio of 44.82, a price-to-earnings-growth ratio of 4.33 and a beta of 0.83. The stock has a 50 day simple moving average of $236.37 and a 200-day simple moving average of $254.34.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter last year, the company earned $2.02 earnings per share. Danaher’s quarterly revenue was up 3.1% compared to the same quarter last year. On average, equities analysts forecast that Danaher will post 7.5 EPS for the current year.
Danaher Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.46%. Danaher’s dividend payout ratio is currently 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- Most Volatile Stocks, What Investors Need to Know
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Most active stocks: Dollar volume vs share volume
- Nebius Group: The Rising Star in AI Infrastructure
- What Are Dividend Champions? How to Invest in the Champions
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.